Social inequalities in adolescent human papillomavirus (HPV) vaccination: A test of fundamental cause theory

Social Science and Medicine

Volumn 82, Issue , 2013, Pages 115-125

  Polonijo, Andrea N ^a   Carpiano, Richard M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Fundamental cause theory; Health inequalities; Human papillomavirus (HPV); United States; Vaccine

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENCE; ETHNIC MINORITY; ETHNICITY; HEALTH CARE; RACIAL DISPARITY; SOCIOECONOMIC STATUS; VACCINATION; VACCINE; VIRUS;

ADOLESCENT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; FUNDAMENTAL CAUSE THEORY; HEALTH DISPARITY; HISPANIC; HUMAN; LOWEST INCOME GROUP; MALE; PARENTAL ATTITUDE; PREVENTIVE HEALTH SERVICE; SOCIAL INEQUALITY; SOCIAL PROBLEM; SOCIAL STATUS; THEORY; VACCINATION;

ADOLESCENT; ADULT; AFRICAN AMERICANS; EMPIRICAL RESEARCH; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTHCARE DISPARITIES; HUMANS; IMMUNIZATION SCHEDULE; MALE; MIDDLE AGED; MODELS, THEORETICAL; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; PHYSICIAN-PATIENT RELATIONS; SOCIAL CLASS; UNITED STATES; VACCINATION;

UNITED STATES;

HUMAN PAPILLOMAVIRUS;

EID: 84875238695     PISSN: 02779536     EISSN: 18735347     Source Type: Journal    
DOI: 10.1016/j.socscimed.2012.12.020     Document Type: Article

References (54)

1. Adler N.E., Stewart J. Health disparities across the lifespan: meaning, methods, and mechanisms. Annals of the New York Academy of Sciences 2010, 1186:5-23.
2. Allen J.D., Othus M.K.D., Shelton R.C., Li Y., Norman N., Tom L., et al. Parental decision making about the HPV vaccine. Cancer Epidemiology, Biomarkers & Prevention 2010, 19(9):2187-2198.
3. Aronowitz R. Gardasil: a vaccine against cancer and a drug to reduce risk. The HPV vaccine and the politics of medicine's simple solutions 2010, 21-38. Johns Hopkins University Press, Baltimore. K. Wailoo, J. Livingston, S. Epstein, R. Aronowitz (Eds.).
4. Barnholtz-Sloan J., Patel N., Rollison D., Kortepeter K., MacKinnon J., Giuliano A. Incidence trends of invasive cervical cancer in the United States by combined race and ethnicity. Cancer Causes & Control 2009, 20:1129-1138.
5. Brewer N.T., Fazekas K.I. Predictors of HPV vaccine acceptability: a theory-informed systematic review. Preventive Medicine 2007, 45:107-114.
6. Carpiano, R. M., & Kelly, B. C. (2007). Scientific knowledge as resource and risk: What does hormone replacement tell us about health disparities? Paper presented at the annual meeting of the American Sociological Association, New York.
7. Carpiano R.M., Link B.G., Phelan J.C. Social inequality and health: future directions for the fundamental cause explanation. Social class: How does it work? 2008, 232-263. Russell Sage Foundation, New York. A. Laureau, D. Conley (Eds.).
8. Casper M.J., Clarke A.E. Making the Pap smear into the 'right tool' for the job: cervical cancer screening in the USA, circa 1940-95. Social Studies of Science 1998, 28(2):255-290.
9. Centers for Disease Control and Prevention (CDC) FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). Morbidity and Mortality Weekly Report 2010, 59(20):626-629.
10. Centers for Disease Control and Prevention (CDC) Cervical cancer rates by race and ethnicity 2011, Accessed 07.08.11. http://www.cdc.gov/features/dscervicalcancer/.
11. Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases, National Center for Health Statistics National Immunization Survey-Teen: A user's guide for the 2009 public-use data file 2010, Accessed 30.11.11. ftp://ftp.cdc.gov/pub/health_statistics/nchs/dataset_documentation/nis/nisteenpuf09dug.pdf.
12. Centers for Disease Control (CDC) U.S. vaccination coverage reported via NIS 2010, Accessed 12.03.11. http://www.cdc.gov/vaccines/statssurv/nis/default.htm#nisteen.
13. Chang V.W., Lauderdale D.S. Fundamental cause theory, technological innovation, and health disparities: the case of cholesterol in the era of statins. Journal of Health and Social Behavior 2009, 50(3):245-260.
14. Dailard C. Achieving universal vaccination against cervical cancer in the United States: the need and the means. Guttmacher Policy Review 2006, 9(4):12-16.
15. Dorell C.G., Jain N., Yankey D. Validity of parent-reported vaccination status for adolescents aged 12-17 years: National Immunization Survey-Teen 2008. Public Health Reports 2011, 126(Suppl. 2):60-69.
16. Dorell C.G., Yankey D.Y., Santibanez T.A., Markowitz L.E. Human papillomavirus vaccination series initiation and completion, 2008-2009. Pediatrics 2011, 128(5):830-839.
17. Downs L.S., Scarinci I., Einstein M.H., Collins Y., Flowers L. Overcoming the barriers to HPV vaccination in high-risk populations in the US. Gynecologic Oncology 2010, 117(3):486-490.
18. Erdman J.N. Health equity, HPV and the cervical cancer vaccine. Health Law Journal 2008, 127-142. Special edition.
19. Freese J., Lutfey K. Fundamental causality: challenges of an animating concept for medical sociology. Handbook of the sociology of health, illness, and healing: A blueprint for the 21st century 2011, 67-81. Springer, New York. B.A. Pescosolido, J.K. Martin, J.D. McLeod, A. Rogers (Eds.).
20. Garner E.I.O. Cervical cancer: disparities in screening, treatment, and survival. Cancer Epidemiology, Biomarkers & Prevention 2003, 12:242s-247s.
21. Gerend M.A., Shepherd J.E. Correlates of HPV knowledge in the era of HPV vaccination: a study of unvaccinated young adult women. Women & Health 2011, 51(1):25-40.
22. Gerend M.A., Weibley E., Bland H. Parental response to human papillomavirus vaccine availability: uptake and intentions. Journal of Adolescent Health 2009, 45(5):528-531.
23. Kwan T.T.C., Tam K.F., Lee P.W.H., Chan K.K.L., Ngan H.Y.S. The effect of school-based cervical cancer education on perceptions towards human papillomavirus vaccination among Hong Kong Chinese adolescent girls. Patient Education and Counseling 2011, 84(1):118-122.
24. Link B.G. Epidemiological sociology and the shaping of population health. Journal of Health and Social Behavior 2008, 49(4):367-384.
25. Link B.G., Northridge M.E., Phelan J.C., Ganz M.L. Social epidemiology and the fundamental cause concept: on the structuring of effective cancer screens by socioeconomic status. Milbank Quarterly 1998, 76(3):375-402.
26. Link B.G., Phelan J. Social conditions as fundamental causes of disease. Journal of Health and Social Behavior 1995, 35(Extra issue):80-94.
27. Link B.G., Phelan J.C. Editorial: understanding sociodemographic differences in health-the role of fundamental social causes. American Journal of Public Health 1996, 86:471-473.
28. Ma B., Roden R., Wu T.C. Current status of HPV vaccines. Journal of Formosan Medical Association 2010, 109(7):481-483.
29. Mamo L., Nelson A., Clark A. Producing and protecting risky girlhoods. The HPV vaccine and the politics of medicine's simple solutions 2010, 121-145. Johns Hopkins University Press, Baltimore. K. Wailoo, J. Livingston, S. Epstein, R. Aronowitz (Eds.).
30. Miech R., Pampel F., Kim J., Rogers R.G. The enduring association between education and mortality: the role of widening and narrowing disparities. American Sociological Review 2011, 76(6):913-934.
31. Mirkin J.N., Bach P.B. Human papillomavirus vaccine coverage - author's reply. The Lancet 2010, 376(9738):330.
32. National Cancer Institute Human papillomavirus (HPV) vaccines 2011, Accessed 03.12.12. http://www.cancer.gov/cancertopics/factsheet/prevention/HPV-vaccine.
33. Newmann S.J., Garner E.O. Social inequalities along the cervical cancer continuum: a structured review. Cancer Causes and Control 2005, 16(1):63-70.
34. Outterson K. Forward - will HPV vaccines prevent cervical cancers among poor women of color? Global health policy at the intersection of human rights and intellectual property law. American Journal of Law and Medicine 2009, 35(2-3):247-252.
35. Palli S.R., Mehta S., Aparasu R.R. Prevalence and predictors of human papillomavirus vaccination in adolescent girls. Journal of the American Pharmacists Association 2012, 52(1):52-58.
36. Phelan J.C., Link B.G., Diez-Roux A., Kawachi I., Levin B. " Fundamental causes" of social inequalities in mortality: a test of the theory. Journal of Health and Social Behavior 2004, 45:265-285.
37. Phelan J.C., Link B.G., Tehranifar P. Social conditions as fundamental conditions of health inequalities: theory, evidence, and policy implications. Journal of Health and Social Behavior 2010, 51:S28-S40.
38. Reiter P.L., Brewer N.T., Gottlieb S.L., McRee A., Smith J.S. Parents' health beliefs and HPV vaccination of their adolescent daughters. Social Science & Medicine 2009, 69(3):475-480.
39. Rosenthal S.L., Rupp R., Zimet G.D., Meza H.M., Loza M.L., Short M.B., et al. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. Journal of Adolescent Health 2008, 43(3):239-245.
40. Rosenthal S.L., Weiss T.W., Zimet G.D., Ma L., Good M.B., Vichnin M.D. Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine 2011, 29(5):890-895.
41. Rouzier R., Giordanella J.P. Coverage and compliance of human papillomavirus vaccines in Paris: demonstration of low compliance with non-school-based approaches. Journal of Adolescent Health 2010, 47(3):237-241.
42. Rubin M.S., Colen C.G., Link B.G. Examination of inequalities in HIV/AIDS mortality in the United States from a fundamental cause perspective. American Journal of Public Health 2010, 100(6):1053-1059.
43. Saslow D., Castle P.E., Cox J.T., Davey D.D., Einstein M.H., Ferris D.G., et al. American Cancer Society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA: A Cancer Journal for Clinicians 2007, 57(1):7-28.
44. Schwartz J.L. HPV vaccination's second act: promotion, competition, and compulsion. American Journal of Public Health 2010, 100(10):1841-1844.
45. Shi L., Stevens G.D. Disparities in access to care and satisfaction among U.S. children: the roles of race/ethnicity and poverty status. Public Health Reports 2005, 120(4):431-441.
46. Singh G.K., Miller B.A., Hankey B.F., Edwards B.K. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer 2004, 101(5):1051-1057.
47. Taylor S.E., Repetti R.L., Seeman T. Health psychology: what is an unhealthy environment and how does it get under the skin?. Annual Review of Psychology 1997, 48:411-447.
48. Tehranifar P., Neugut A.I., Phelan J.C., Link B.G., Liao Y., Desai M., et al. Medical advances and racial/ethnic disparities in cancer survival. Cancer Epidemiology, Biomarkers & Prevention 2009, 18:2701-2708.
49. U.S.Department of Health and Human Services (DHHS) National Center for Health Statistics. The 2008 National Immunization Survey - Teen 2009, Centers for Disease Control and Prevention, Hyattsville, MD.
50. U.S.Department of Health and Human Services (DHHS) National Center for Health Statistics. The 2009 National Immunization Survey - Teen 2010, Centers for Disease Control and Prevention, Hyattsville, MD.
51. U.S.Department of Health and Human Services (DHHS) National Center for Health Statistics. The 2010 National Immunization Survey - Teen 2011, Centers for Disease Control and Prevention, Hyattsville, MD.
52. Wang A., Clouston S.A., Rubin M.S., Colen C.G., Link B.G. Fundamental causes of colorectal cancer mortality: the implications of informational diffusion. Milbank Quarterly 2012, 90(3):592-618.
53. Watson M., Saraiya M., Benard V., Coughlin S.S., Flowers L., Cokkinides V., et al. Burden of cervical cancer in the United States, 1998-2003. Cancer 2008, 113(10 Suppl.):2855-2864.
54. Zimmerman R.K. Ethical analysis of HPV vaccine policy options. Vaccine 2006, 24(22):4812-4820.